US · Financial Services

Xtacy Therapeutics Corp. (XTCYF)

Credit Services

Xtacy Therapeutics Corp. (XTCYF) is listed on US in the Financial Services sector. Industry: Credit Services. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XTCYF

P/E ratio

18.00

Xtacy Therapeutics Corp. (XTCYF) — FAQ

What is XTCYF's P/E ratio?

The price-to-earnings (P/E) ratio for Xtacy Therapeutics Corp. (XTCYF) is 18.00 (data as of 2026-05-23).

Does Xtacy Therapeutics Corp. pay a dividend?

Dividend yield is not available in the current snapshot for Xtacy Therapeutics Corp. (XTCYF). Check the MyAverix Finance app for the latest dividend data.

What sector is Xtacy Therapeutics Corp. in?

Xtacy Therapeutics Corp. (XTCYF) is classified in the Financial Services sector (Credit Services industry).

What exchange is XTCYF listed on?

XTCYF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Financial Services companies

Administradora Americana de Inversiones S.A. (AAISA) Aflac Incorporated (A1FL34) Agricultural Bank Of China (1288) AIA Group Ltd (1299) American International Group, Inc. (AIGB34) Ameriprise Financial Inc. (A1MP34) Arthur J. Gallagher & Co. (A1JG34) Banco Santander S.A. (BSD2)